VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE REPURCHASE

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026

2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

ANNUAL REPORT 2025

ANNUAL REPORT 2025

PROPOSED ADOPTION OF RESTRICTED SHARE UNIT INCENTIVE SCHEME

Boan Biotech Announces CDE Acceptance of Phase Ⅱ Clinical Trial Application for BA1106 in Combination with BA1104 for NSCLC

Yantai, April 4th, 2026 –- Boan Biotech announced today that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has accepted the application for a Phase ...

VOLUNTARY ANNOUNCEMENT CDE ACCEPTANCE OF PHASE II CLINICAL TRIAL APPLICATION FOR BA1106 IN COMBINATION WITH BA1104 FOR NSCLC

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS